Dose‐response studies with benazepril in mild to moderate hypertension

Clinical Cardiology

Volumn 14, Issue 4 S, 1991, Pages 22-27

  Gomez, Hector J ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

ACE inhibitors; benazepril; dose response; hypertension

Indexed keywords

BENAZEPRIL; HYDROCHLOROTHIAZIDE; PLACEBO;

BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DOSE; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; HYPERTENSION; TIME FACTORS;

EID: 0025783510     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.4960141803     Document Type: Article

References (16)

1. Benefits of low vs high dosages of diuretics
2. Angiotensin‐converting enzyme inhibitors: Past, present, and bright future
3. Determination of the optimal dose of antihypertensive drugs
4. Determination of the therapeutically useful dose range of antihypertensive drugs
5. Lisinopril: Dose‐response relationship in essential hypertension
6. Effective dose range of enalapril in mild to moderate essential hypertension
7. Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers
8. A Monte Carlo comparison of three up‐and‐down designs for dose ranging
9. Lisinopril: Efficacy and tolerability in special populations
10. Definition of the effective dose of the converting‐enzyme inhibitor benazepril
11. Diurnal blood pressure in patients with mild‐to‐moderate hypertension treated with once‐daily benazepril hydrochloride
12. The dose‐response relationship of benazepril once‐daily to reduction of blood pressure in patients with mild‐to‐moderate hypertension
13. Double‐blind comparison of benazepril, hydrochlorothiazide, and placebo in mild to moderate hypertension
14. Double‐blind comparison of once daily benazepril, hydrochlorothiazide and placebo in mild to moderate hypertension
15. Peak and trough effects of benazepril in mild‐moderate hypertension (abstr)
16. Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension